危重患儿气管插管使用氯胺酮与较少的血流动力学不良事件相关
该研究基于2013至2017年国家儿童急诊气道登记(NEAR4KIDS)数据库,纳入40个国际PICU中0-17岁接受气管插管的危重患儿10750例,其中32.0%(n=3436)以氯胺酮为诱导剂,最常见诊断是脓毒症和/或休克(49.7%)。采用多因素logistic回归调整患者、操作者和实践因素及站点聚类后,氯胺酮使用与较少的血流动力学插管相关不良事件(心律失常、低血压、心脏骤停)相关(调整OR 0.74;95%CI 0.58-0.95)。氯胺酮使用与休克适应证的交互项无统计学意义(p=0.11),提示氯胺酮预防血流动力学不良事件的效应在休克与非休克患儿中一致。
要点
- 在10750例危重患儿气管插管中,32.0%(n=3436)使用氯胺酮诱导,调整混杂因素和站点后与较少的血流动力学不良事件相关(调整OR 0.74;95%CI 0.58-0.95)。
- 氯胺酮使用与休克适应证的交互项无统计学意义(p=0.11),提示其减少血流动力学不良事件的效应在休克与非休克患儿中一致。
- 使用氯胺酮的最常见诊断是脓毒症和/或休克(49.7%)。
- 血流动力学插管相关不良事件包括心律失常、低血压和心脏骤停。
适用人群与场景
- 0-17岁在PICU接受气管插管的危重患儿,来自参与国家儿童急诊气道登记(NEAR4KIDS)的40个国际PICU,数据收集于2013至2017年。
- 使用氯胺酮的最常见诊断是脓毒症和/或休克(49.7%)。
研究设计与关键结果
- 研究类型为回顾性分析,使用2013至2017年前瞻性收集的观察性数据(国家儿童急诊气道登记NEAR4KIDS数据库),纳入40个国际PICU的10750例气管插管。
- 暴露为氯胺酮作为诱导剂,对照为其他诱导剂,主要结局为气管插管期间的血流动力学不良事件(心律失常、低血压、心脏骤停)。
- 10750例插管中32.0%(n=3436)使用氯胺酮诱导;调整患者、操作者和实践因素及站点聚类后,氯胺酮使用与较少的血流动力学插管相关不良事件相关(调整OR 0.74;95%CI 0.58-0.95)。
- 氯胺酮使用与休克适应证的交互项无统计学意义(p=0.11),提示氯胺酮预防血流动力学不良事件的效应在休克与非休克患儿中一致。
证据类型、等级与局限
- 证据类型:基于前瞻性收集观察性数据的回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,危重患儿气管插管使用氯胺酮与较少的血流动力学插管相关不良事件相关。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Tracheal intubation in critically ill children with shock poses a risk of hemodynamic compromise. Ketamine has been considered the drug of choice for induction in these patients, but limited data exist. We investigated whether the administration of ketamine for tracheal intubation in critically ill children with or without shock was associated with fewer adverse hemodynamic events compared with other induction agents. We also investigated if there was a dose dependence for any association between ketamine use and adverse hemodynamic events.
DESIGN: We performed a retrospective analysis using prospectively collected observational data from the National Emergency Airway Registry for Children database from 2013 to 2017.
SETTING: Forty international PICUs participating in the National Emergency Airway Registry for Children.
PATIENTS: Critically ill children 0-17 years old who underwent tracheal intubation in a PICU.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The association between ketamine exposure as an induction agent and the occurrence of adverse hemodynamic events during tracheal intubation including dysrhythmia, hypotension, and cardiac arrest was evaluated. We used multivariable logistic regression to account for patient, provider, and practice factors with robust SEs to account for clustering by sites. Of 10,750 tracheal intubations, 32.0% (n = 3,436) included ketamine as an induction agent. The most common diagnoses associated with ketamine use were sepsis and/or shock (49.7%). After adjusting for potential confounders and sites, ketamine use was associated with fewer hemodynamic tracheal intubation associated adverse events compared with other agents (adjusted odds ratio, 0.74; 95% CI, 0.58-0.95). The interaction term between ketamine use and indication for shock was not significant (p = 0.11), indicating ketamine effect to prevent hemodynamic adverse events is consistent in children with or without shock.
CONCLUSIONS: Ketamine use for tracheal intubation is associated with fewer hemodynamic tracheal intubation-associated adverse events.
参考来源
- Conway JA, Kharayat P, Sanders RC, et al. Ketamine Use for Tracheal Intubation in Critically Ill Children Is Associated With a Lower Occurrence of Adverse Hemodynamic Events. Crit Care Med. 2020. PMID: 32317603. doi:10.1097/CCM.0000000000004314
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。